BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19236739)

  • 21. [FLT3 gene overexpression and its clinical significance in acute myeloid leukemia with AML1/ETO fusion gene positive].
    Xie HM; Gao L; Wang N; Xu YY; Shi JL; Yu L; Wang LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1199-205. PubMed ID: 25338557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.
    Huang S; Jiang MM; Chen GF; Qian K; Gao HH; Guan W; Shi JL; Liu AQ; Liu J; Wang BH; Li YH; Yu L
    Chin Med J (Engl); 2016 Jun; 129(11):1355-62. PubMed ID: 27231175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and monitoring of AML1-MTG8 (ETO)-positive acute myeloid leukemia by qualitative and real-time quantitative RT-PCR.
    Tobal K; Liu Yin JA
    Methods Mol Med; 2006; 125():149-61. PubMed ID: 16502583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [GATA-2 gene overexpression and its clinical significance in acute myeloid leukemia with AML1/ETO fusion gene].
    Xie HM; Gao L; Wang N; Xu YY; Li YH; Yu L; Wang LL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):664-9. PubMed ID: 25286696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlations Between
    Wang XM; Ye YX; Yang L; Lu XJ; Ying BW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):931-935. PubMed ID: 28598127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smears.
    Tsukamoto N; Karasawa M; Tanaka Y; Yokohama A; Uchiumi H; Matsushima T; Murakami H; Nojima Y
    Int J Hematol; 2003 Nov; 78(4):362-9. PubMed ID: 14686496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Transcriptome Study of Subtype M2 Acute Myeloblastic Leukemia.
    Wu AY; Yang HC; Lin CM; Wu BD; Qu QS; Zheng YH; Wei H; Mei XQ; Zeng ZH; Ma XD
    Cell Biochem Biophys; 2015 Jul; 72(3):653-6. PubMed ID: 27352183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of autologous peripheral blood stem cell transplantation in 13 patients with AML1/ETO (+) acute myeloid leukemia].
    Zhang QY; Huang WR; Dou LP; Deng AL; Fu L; Xu YH; Liu ZX; Li YH; Wang N; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):447-52. PubMed ID: 24763021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of c-kit mRNA predicts unfavorable outcome in adult patients with t(8;21) acute myeloid leukemia.
    Gao X; Lin J; Gao L; Deng A; Lu X; Li Y; Wang L; Yu L
    PLoS One; 2015; 10(4):e0124241. PubMed ID: 25860287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The application of competitive RT-PCR to detect minimal residual disease in patients with 8;21 translocation].
    Wang Y; Seng M; Guo Y; Lu D; Chen Z; Xue Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Dec; 17(6):435-8. PubMed ID: 11110985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.
    Kusec R; Laczika K; Knöbl P; Friedl J; Greinix H; Kahls P; Linkesch W; Schwarzinger I; Mitterbauer G; Purtscher B
    Leukemia; 1994 May; 8(5):735-9. PubMed ID: 7514242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients.
    Morschhauser F; Cayuela JM; Martini S; Baruchel A; Rousselot P; Socié G; Berthou P; Jouet JP; Straetmans N; Sigaux F; Fenaux P; Preudhomme C
    J Clin Oncol; 2000 Feb; 18(4):788-94. PubMed ID: 10673520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21).
    Leroy H; de Botton S; Grardel-Duflos N; Darre S; Leleu X; Roumier C; Morschhauser F; Lai JL; Bauters F; Fenaux P; Preudhomme C
    Leukemia; 2005 Mar; 19(3):367-72. PubMed ID: 15674426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial quantification of minimal residual disease of t(8;21) acute myelogenous leukaemia with RT-competitive PCR assay.
    Muto A; Mori S; Matsushita H; Awaya N; Ueno H; Takayama N; Okamoto S; Kizaki M; Ikeda Y
    Br J Haematol; 1996 Oct; 95(1):85-94. PubMed ID: 8857943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.
    Jurlander J; Caligiuri MA; Ruutu T; Baer MR; Strout MP; Oberkircher AR; Hoffmann L; Ball ED; Frei-Lahr DA; Christiansen NP; Block AM; Knuutila S; Herzig GP; Bloomfield CD
    Blood; 1996 Sep; 88(6):2183-91. PubMed ID: 8822938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
    Krauter J; Gorlich K; Ottmann O; Lubbert M; Dohner H; Heit W; Kanz L; Ganser A; Heil G
    J Clin Oncol; 2003 Dec; 21(23):4413-22. PubMed ID: 14645432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.
    Fu L; Huang W; Jing Y; Jiang M; Zhao Y; Shi J; Huang S; Xue X; Zhang Q; Tang J; Dou L; Wang L; Nervi C; Li Y; Yu L
    FEBS J; 2014 Feb; 281(4):1123-31. PubMed ID: 24314118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between AML1-ETO and MLL-AF9 fusion gene expressions and hematological parameters in acute myeloid leukemia.
    Muddathir ARM; Hamid TAM; Mohamed Elamin E; Khabour OF
    Gulf J Oncolog; 2020 Sep; 1(34):65-69. PubMed ID: 33431365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow.
    Inokuchi K; Iwakiri R; Futaki M; Hanawa H; Tanosaki S; Nomura T; Dan K
    Leuk Lymphoma; 1998 May; 29(5-6):553-61. PubMed ID: 9643569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.